Press Releases GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile® Therapy for Newly Diagnosed Glioblastoma Brain Tumors Enrolling Newly Diagnosed Patients with Glioblastoma in the GESTALT Clinical Trial